Acute kidney injury (AKI) represents a group of complicated syndromes with a high mortality
rate. The administration of adipose‐derived mesenchymal stem cells (ADMSC s) has been …

Acute kidney injury (AKI) is a complex clinical condition associated with significant morbidity
and mortality and lacking effective management. Ischemia‑reperfusion injury (IRI) remains …

Objective (s): It has been shown that adipose-derived mesenchymal stem cells (AD-MSC)
have protective effects in acute kidney injury (AKI). This study was conducted to assess the …

Background Acute kidney injury (AKI) is a critical condition for kidney and other remote
organs, including the lung. However, available treatments for AKI are limited. In this study …

Stem cells therapy has been suggested as a promising option for the treatment of acute
kidney injury (AKI). This study was performed to compare the abilities of xenogenic …

Introduction This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic
adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of …

Acute kidney injury (AKI) is a rapid loss of renal function. It has high mortality rates. Still,
renal replacement therapy is considered the best solution for recovering AKI. This opens a …

Background. Acute kidney injury (AKI) represents a major clinical problem with high mortality
and limited causal treatments. The use of cell therapy has been suggested as a potential …

It has been shown that administration of adipose derived mesenchymal stem cells
(AdMSCs) enhanced structural and functional recovery of renal ischemia‐reperfusion (IR) …

The recent findings indicate that under conditions of severe tubular injuries, transplantation
of mesenchymal stem cells (MSCs) may be a promising treatment in acute kidney diseases; …